|09 April 2017 by Helen Robertson|
Details of the world's first successful use of mitochondrial replacement therapy (MRT) in IVF have been published.
Although the birth of a healthy baby to a mother carrying the mitochondrial mutation for Leigh Syndrome was announced in the press last year, the scientific details had not been revealed until now, and have raised both positive reactions and concerns from experts.[Read more]
|02 April 2017 by Rachel Reeves|
The movement of sperm can be explained by a relatively simple mathematical formula, according to new research.
The research team – from the Universities of York, Birmingham, Oxford and Kyoto University, Japan – believe that this formula will remove the need for complex, expensive computer simulations currently required to understand how sperm moves through fluid. It could help them to understand how larger groups of sperm move and interact, and provide new insights into treating male infertility by explaining why some men's sperm don't swim strongly enough to fertilise an egg.[Read more]
|02 April 2017 by Rikita Patel|
New patients referred for infertility treatment by their doctors will now have access to three cycles of IVF on the NHS in Scotland.
'We want to make access to treatment on the NHS as fair as possible - giving more people the opportunity to conceive. Over the last five years we have invested around £24 million to reduce IVF waiting times and improve the outcomes for couples' said Aileen Campbell, Scottish Government Minister for Public Health.[Read more]
|02 April 2017 by Dr Rachel Huddart|
Rapid advances in stem cell and embryo research are in danger of outstripping current ethical guidelines and new regulations are urgently needed, warn scientists in a report published this week.
'Synthetic' structures – such as organoids or embryos assembled from stem cells in the lab – are increasingly being used in cutting-edge research. These structures, referred to in the report as 'synthetic human entities with embryo-like features' (SHEEFs), are becoming increasingly sophisticated, and even more complex examples could soon be seen – for example, a rudimentary brain connected to a beating heart.[Read more]
|02 April 2017 by Annabel Slater|
The US Centers for Disease Control (CDC) has identified a potential risk of Zika virus transmission from donor sperm in the Florida tri-county area.
Zika virus infection during pregnancy can cause brain abnormalities, microcephaly, and congenital Zika syndrome. Now officials have found more people in the area may have been infected by Zika than previously thought, and could have donated infected sperm.[Read more]
|02 April 2017 by Meetal Solanki|
A study has revealed a possible link between unsuccessful fertility treatments and a higher risk of developing cardiovascular disease.
Researcher found that women who did not become pregnant after fertility treatment had a 19 percent higher cardiovascular risk of experiencing cardiac events compared with women who had become pregnant following treatment.[Read more]
|02 April 2017 by Sarah Pritchard|
Croydon has become the first Clinical Commissioning Group (CCG) in London to cut funding for all IVF treatment, other than in 'exceptional circumstances'.
The decision was made by the CCG as part of efforts to plug the its £36 million financial deficit, estimating that stopping funding one cycle of IVF for infertile couples will save up to £860,000 per year.[Read more]
|02 April 2017 by Georgia Everett|
Doctors at Newcastle Fertility Centre have been granted the first UK licence to use mitochondrial donation as a fertility treatment to prevent the inheritance of mitochondrial disease.
The technique, which involves the creation of an embryo derived from the mother, father and a healthy female mitochondrial donor, was approved for clinical use by the Human Fertilisation and Embryology Authority (HFEA) in December 2016, but the Newcastle group is the first to have a licence approved by the regulator.[Read more]
|20 March 2017 by ALPHA|
ALPHA's 12th Biennial Conference will take place 17-20 May, 2018 at the Hilton Reykjavik Nordica, Reykjavík, Iceland.[Read more]
|19 March 2017 by Dr Katie Howe|
Chinese scientists have successfully used genome editing to correct mutations in viable human embryos for the first time.
The study used CRISPR technology, which has previously been used to edit genes in non-viable human embryos. These attempts had very low success rates but it was not known if this was because the embryos had an extra set of chromosomes.[Read more]